Captopril in cardiological patients treatment: is there still place for the “first of the Mohicans”?

Captopril in cardiological patients treatment: is there still place for the “first of the Mohicans”?

Aim. To demonstrate significance and relevancy of the first angiotensin-converting enzyme inhibitor (ACE inhibitor) captopril use in treatment of patients with cardiovascular disorders. Materials and methods. The article covers the issues of captopril use launch, results of the main randomized clin...

Full description

Bibliographic Details
Main Authors: Farogat Yu. Valikulova, Liubov Yu. Koroleva, Olesia V. Melnichenko, Elena M. Durygina, Fazliniso N. Muradova, Mariia M. Alekseeva
Format: Article
Language:Russian
Published: ZAO "Consilium Medicum" 2019-01-01
Series:Consilium Medicum
Subjects:
angiotensin-converting enzyme inhibitor
sulfhydryl group
captopril
hypertensive crisis
arterial hypertension
diabetes mellitus
myocardial infarction
congestive heart failure
Online Access:http://consilium.orscience.ru/en/archive/2019/vol-21-1-2019/captopril-in-cardiological-patients-treatment-is-there-still-place-for-the-first-of-the-mohicans-_5102/?element

Internet

http://consilium.orscience.ru/en/archive/2019/vol-21-1-2019/captopril-in-cardiological-patients-treatment-is-there-still-place-for-the-first-of-the-mohicans-_5102/?element

Similar Items